These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19349555)
1. Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes. Pellegrin M; Alonso F; Aubert JF; Bouzourene K; Braunersreuther V; Mach F; Haefliger JA; Hayoz D; Berthelot A; Nussberger J; Laurant P; Mazzolai L Hypertension; 2009 May; 53(5):782-9. PubMed ID: 19349555 [TBL] [Abstract][Full Text] [Related]
2. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092 [TBL] [Abstract][Full Text] [Related]
3. Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability. Pellegrin M; Bouzourène K; Aubert JF; Nahimana A; Duchosal MA; Mazzolai L Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181481 [TBL] [Abstract][Full Text] [Related]
4. Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects. Pellegrin M; Aubert JF; Bouzourène K; Amstutz C; Mazzolai L PLoS One; 2015; 10(11):e0143536. PubMed ID: 26600018 [TBL] [Abstract][Full Text] [Related]
5. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Mazzolai L; Duchosal MA; Korber M; Bouzourene K; Aubert JF; Hao H; Vallet V; Brunner HR; Nussberger J; Gabbiani G; Hayoz D Hypertension; 2004 Sep; 44(3):277-82. PubMed ID: 15302839 [TBL] [Abstract][Full Text] [Related]
6. Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. Pellegrin M; Szostak J; Bouzourène K; Aubert JF; Berthelot A; Nussberger J; Laurant P; Mazzolai L J Cardiovasc Pharmacol Ther; 2017 Mar; 22(2):159-168. PubMed ID: 27246357 [TBL] [Abstract][Full Text] [Related]
7. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis. Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [TBL] [Abstract][Full Text] [Related]
9. Long-term exercise stabilizes atherosclerotic plaque in ApoE knockout mice. Pellegrin M; Miguet-Alfonsi C; Bouzourene K; Aubert JF; Deckert V; Berthelot A; Mazzolai L; Laurant P Med Sci Sports Exerc; 2009 Dec; 41(12):2128-35. PubMed ID: 19915507 [TBL] [Abstract][Full Text] [Related]
10. Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency. Brown NJ; Bradford J; Wang Z; Lea W; Ma L; Ma J; Vaughan DE; Fogo AB Kidney Int; 2007 Jul; 72(1):72-81. PubMed ID: 17429342 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370 [TBL] [Abstract][Full Text] [Related]
12. Valsartan Promoting Atherosclerotic Plaque Stabilization by Upregulating Renalase: A Potential-Related Gene of Atherosclerosis. Zhou M; Ma C; Liu W; Liu H; Wang N; Kang Q; Li P J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):509-19. PubMed ID: 25818930 [TBL] [Abstract][Full Text] [Related]
13. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis. Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539 [TBL] [Abstract][Full Text] [Related]
14. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. Schulman IH; Zhou MS; Raij L J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573 [TBL] [Abstract][Full Text] [Related]
15. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. Bernardi S; Candido R; Toffoli B; Carretta R; Fabris B Nephrol Dial Transplant; 2011 Mar; 26(3):832-8. PubMed ID: 20810455 [TBL] [Abstract][Full Text] [Related]
16. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935 [TBL] [Abstract][Full Text] [Related]
17. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Shao J; Nangaku M; Miyata T; Inagi R; Yamada K; Kurokawa K; Fujita T Hypertension; 2003 Jul; 42(1):31-8. PubMed ID: 12771047 [TBL] [Abstract][Full Text] [Related]